These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 27910065

  • 21. Molecular Genetics of Endometrial Carcinoma.
    Bell DW, Ellenson LH.
    Annu Rev Pathol; 2019 Jan 24; 14():339-367. PubMed ID: 30332563
    [Abstract] [Full Text] [Related]

  • 22. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM, Kipp BR, Halling KC, Kerr SE, Smith DI, Distad TJ, Clayton AC, Medeiros F.
    Int J Gynecol Pathol; 2012 May 24; 31(3):195-205. PubMed ID: 22498935
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Molecular pathology of endometrial hyperplasia and carcinoma.
    Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Muñoz J, Argüelles R, Machin P, Prat J.
    Hum Pathol; 2001 Jun 24; 32(6):569-77. PubMed ID: 11431710
    [Abstract] [Full Text] [Related]

  • 27. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
    Demopoulos RI, Mesia AF, Mittal K, Vamvakas E.
    Int J Gynecol Pathol; 1999 Jul 24; 18(3):233-7. PubMed ID: 12092593
    [Abstract] [Full Text] [Related]

  • 28. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S.
    Pathologe; 2011 Nov 24; 32 Suppl 2():255-64. PubMed ID: 22033684
    [Abstract] [Full Text] [Related]

  • 29. Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.
    Yasue A, Hasegawa K, Udagawa Y.
    Hum Cell; 2011 Jun 24; 24(2):65-73. PubMed ID: 21547354
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J.
    Verh Dtsch Ges Pathol; 2005 Jun 24; 89():77-83. PubMed ID: 18035676
    [Abstract] [Full Text] [Related]

  • 34. [Endometrial carcinoma and precursor lesions].
    Djordjević B, Stanojević Z.
    Srp Arh Celok Lek; 2007 Jun 24; 135(3-4):230-4. PubMed ID: 17642468
    [Abstract] [Full Text] [Related]

  • 35. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
    Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K, ANECS, Akslen LA, Claes B, Vergote I, Moerman P, Van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F.
    Gynecol Oncol; 2013 Feb 24; 128(2):327-34. PubMed ID: 23219661
    [Abstract] [Full Text] [Related]

  • 36. Pathology of endometrioid carcinoma.
    Albertini AF, Devouassoux-Shisheboran M, Genestie C.
    Bull Cancer; 2012 Jan 24; 99(1):7-12. PubMed ID: 22231875
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.